HomeAboutSurveysExpertsInsightsPublicationsContact
CLOSE MENU
CLOSE SEARCH
About
Experts
Surveys
Insights
Publications
Menu

Publications

Estimated Payments Under the Inflation Penalty in the Build Back Better Act
March 1, 2022
READ MORE
Federal Revenue Generated by Extending Drug Price Inflation Caps to the Commercial Market
November 3, 2021
READ MORE
Impact Estimate of a $2,000 Out-of-Pocket Cap in Medicare Part D
October 27, 2021
READ MORE
Estimated Medicare Savings from Domestic Reference Pricing
September 23, 2021
READ MORE
Drug Pricing Policy Savers Playbook
August 19, 2021
READ MORE
Will Reducing Drug Prices Slow Innovation?
August 12, 2021
READ MORE
Extending PBM Rebates to Medicare Beneficiaries Without Increasing Medicare Spending
July 22, 2021
READ MORE
Commercial Savings Generated by Medicare Negotiation Under H.R. 3
May 20, 2021
READ MORE
High Drug Prices and Patient Costs: Millions of Lives and Billions of Dollars Lost
November 18, 2020
Cost related non-adherence could cause 1.1 million seniors to die prematurely by 2030
READ MORE
How Much Can Pharma Lose?
July 7, 2020
A Comparison of Returns Between Pharmaceutical and Other Industries
READ MORE
media@cidsa.org

Terms and ConditionsPrivacy Policy
© 2020 West Health
HomeAboutExpertsSurveysInsightsPublicationsContact
We are an independent, nonpartisan expert group funded by West Health and focused on bringing a non-pharma perspective to drug spending policy dialogue.
West Health is dedicated to lowering healthcare costs to enable seniors to successfully age in place with access to high-quality, affordable health and support services that preserve and protect their dignity, quality of life and independence.